Skip to search formSkip to main contentSkip to account menu

Delayed Release Tablet Dosage Form

Known as: Tablet, delayed release, Delayed Release Tablet Dose Form, TAB DR 
A tablet that has been coated with a substance that is designed to impede the immediate release of the active and/or inert ingredient(s) after… 
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Pharmaceutical Dosage Form TerminologyClinical Data Interchange Standards Consortium TerminologyStructured Product Labeling Pharmaceutical Dosage Form Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Posaconazole delayed‐release tablets in paediatric haematology–oncology patients
To date, there are few studies that describe pharmacokinetics, safety and efficacy of posaconazole delayed‐release tablet (DRT… 
2014
2014
Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.
The main objective behind this study was to formulate delayed release colon targeted tablet of Mebendazole by using different… 
2014
2014
FORMULATION AND EVALUATION OF ENTERIC COATING TABLETS BY WET GRANULATION METHOD
Serratiopeptidase is derived from bacteria belonging to genus Serratia. Serratiopeptidase tablets used in the treatment of viral… 
2013
2013
FORMULATION AND EVALUATION OF ESOMEPRAZOLE DELAYED RELEASE TABLETS
In the present work emphasize on Esomeprazole magnesium is formulated as delayed release tablets to provide desired effect at… 
2013
2013
Formulation and evaluation of enteric coated tablet of Ilaprazole.
The present study was an attempt to formulate and evaluate enteric coated tablets for Ilaprazole to reduce the gastrointestinal… 
2009
2009
Preparation of delayed release tablet dosage forms by compression coating: Effect of coating material on theophylline release
In this study, compression-coated tablets were prepared and examined by real-time swelling/erosion analysis and dissolution… 
2009
2009
Formulation and Evaluation of Clarithromycin Extended Release Tablets
The Present study to investigate the formulation development of orally administrable Clarithromycin delayed release tablet… 
Highly Cited
2008
Highly Cited
2008
Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms
PurposeThe study was designed to evaluate the effect of delayed release (DR) on absorption and bioavailability of intestinally… 
2007
2007
LIALDATM (mesalamine) Delayed Release Tablets DESCRIPTION Each LIALDA delayed release tablet for oral administration contains 1.2g 5-aminosalicylic acid (5-ASA; mesalamine), an anti-inflammatory…
The mechanism of action of mesalamine is not fully understood, but appears to be topical. Mucosal production of arachidonic acid… 
2001
2001
Bioavailability and stability of erythromycin delayed release tablets.
BACKGROUND Erythromycin is available as the free base, ethylsuccinate, estolate, stearate, gluceptate, and lactobionate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)